Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Ann Pharm Fr ; 80(6): 803-809, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-35476972

RESUMO

BACKGROUND: Implant port catheters have became essential tools in the management of patients receiving intravenous chemotherapy. However; these devices expose to significant complications. We report an experiment aimed at studying the prevalence of complications induced by implant port catheters and the risk factors that result. METHODS: This is a retrospective study over one year (from January, to December 2019) including 100 patients treated in the carcinology department of our hospital and having presented complications from their port catheters implantable. RESULTS: During the study period, 100 patients benefited from placement of the implantable chamber catheter. The average age is 53years with extremes of 25years and 72years. Twenty-six percent of patients had at least one complication. Those complications were mechanical in 53.84% of the patients, infectious in 19.23% and thromboembolic in 19.23%. DISCUSSION: Patients experiencing complication did not differ with respect to age, body mass index, cancer category, medical and surgical history, and insertion side of the implantable chamber catheter.


Assuntos
Cateterismo Venoso Central , Neoplasias , Humanos , Pessoa de Meia-Idade , Cateteres de Demora/efeitos adversos , Estudos Retrospectivos , Neoplasias/tratamento farmacológico , Fatores de Risco , Próteses e Implantes , Cateterismo Venoso Central/efeitos adversos
2.
Ann Pharm Fr ; 78(2): 158-166, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32037026

RESUMO

OBJECTIVE: To date, few adapted pharmaceutical forms are available for infants leading to multiple steps of preparation and medicines dilution before administration. The main purpose of this study was to assess the risks on the steps of preparation and administration of medicines in a neonatal care unit and to propose corrective actions to ensure the medicines safety. METHODS: A global risk analysis was performed, conducted by a multidisciplinary working group of 9 experts, that is 9 meetings. RESULTS: We identified 57 scenarios: 59,6% of scenarios had an initial criticality C1, 31,6% C2 and 8,8% C3. The most risky phases were phases of needs identification including the step of doses calculation and phases of preparation. The strategic management together with the human factor were the most risky dangers. Nineteen corrective actions were proposed. After implementing those actions, 82,5% of scenarios had residual criticality C1, 17,5% C2 and no scenario had residual criticality C3. Follow-up actions have been implemented to control the residual risk as in service training. CONCLUSION: Neonatal unit care is a risky service and should be a priority in the risk management policy. This analysis joins the quality policy implemented in the hospital and similar risk analysis is on process.


Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/prevenção & controle , Nutrição Enteral/efeitos adversos , Alimentos Formulados/efeitos adversos , Protocolos Clínicos , Composição de Medicamentos , Equipamentos e Provisões/efeitos adversos , Implementação de Plano de Saúde , Unidades Hospitalares , Humanos , Lactente , Recém-Nascido , Erros de Medicação , Segurança do Paciente , Medição de Risco , Gestão de Riscos
3.
Can J Microbiol ; 53(2): 277-83, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17496977

RESUMO

The rhizobia present in a single arid region Tunisian soil that nodulate Medicago laciniata and Medicago truncatula were compared. All isolates, 40 from each host, were Sinorhizobium meliloti based on 16S rRNA polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) patterns and subsequent confirmation by sequence analysis of the 16S rRNA genes in four representatives from each host species. There was no apparent relationship between Medicago host species of isolation and the nodulating rhizobial genome as determined by repetitive extragenic palandromic PCR. The isolates of M. laciniata were distinguished from those of M. truncatula present in the same soil by variation in PCR-RFLP of nifDK, indicating that this dissimilarity is originally genetic and not geographic. While forming effective symbioses with their own respective isolates, both M. laciniata and M. truncatula formed ineffective true nodules, nodule-like structures, or no nodules at all in cross-inoculation tests, as confirmed by the histological observations.


Assuntos
Medicago truncatula/microbiologia , Medicago/microbiologia , Sinorhizobium meliloti/genética , Microbiologia do Solo , Variação Genética , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , RNA Ribossômico 16S/genética , Simbiose
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa